The goal of this clinical trial is to learn if ESP block is safe and effective for perioperative analgesia in patients undergoing liver transplant. The main question it aims to answer are Is ESP block safe and has a minimum side effects, like hematoma? Is it effective for perioperative analgesia? Researchers will compare the results to a group of patients who underwent liver transplants without any regional anaesthesia techniques. Participants will receive bilateral thoracic ESP block on the day of the transplantation with a subsequent bilateral catheterization.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Pain reduction postoperative
Timeframe: from enrollment to the 2nd postoperative day
Opioid reduction intraoperatively
Timeframe: from enrollment to the end of the operation
Need for opioids postoperatively
Timeframe: from enrollment to the 2nd postoperative day